Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex DDI with Stiripentol or Valproate in Epilepsy (OLE)
NCT02607904Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of cannabidiol in epilepsy, sponsored by Jazz Pharmaceuticals plc. Started Dec 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02607904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607904.